Patient Directed Strategies for Cardiac Arrhythmia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey
研究概览
简要总结
In this patient engagement study, patients and partners will attend a presentation, group meeting and responding to the survey to help the research team gage the acceptability of using a biological therapy to prevent cardiac arrhythmia. Patient Partners will also help to clarify which outcomes are important to patients, to ensure the selected outcomes align with patient interests.
详细描述
There will be four study groups:
- Heart patients who experienced a cardiac arrhythmia while in hospital,
- Heart patients who did not experience a cardiac arrhythmia while in hospital,
- Heart patients with an upcoming procedure that have not had a cardiac arrhythmia,
- Members of the general public.
There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Inability to complete an electronic survey or participate in a small group meeting.
结局指标
主要结局
Number of participants that would accept a biological therapy for a cardiac arrhythmia as assessed using a survey
时间窗: 2 years
accept a biological therapy
次要结局
未报告次要终点
研究者
Darryl Davis
Principal Investigator
Ottawa Heart Institute Research Corporation